Key Points
Research suggests Trump's tariffs are likely impacting US-based orthopedic medical device companies, increasing costs and disrupting supply chains.
It seems likely that orthopedic devices face a 10% global tariff and higher reciprocal tariffs, with China's effective rate at 54% as of April 9, 2025.
The evidence leans toward higher prices for patients and potential job losses, with industry groups lobbying for exemptions without success as of April 11, 2025.
Background
President Donald Trump's tariff policies, announced in early 2025, introduced a 10% global tariff on all imports,...
